突变诱导的神经元和人性化小鼠可以识别尼曼-皮克型C1蛋白静止疗法
Ruth D Azaria1, Adele B Correia1, Kylie J Schache1
1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
JCI insight
|August 29, 2024
概括
研究人员确定mo56-hydroxycholesterol (mo56Hc) 是一个强大的药理伴侣,可以纠正尼曼-皮克型C1疾病 (NPC1) 蛋白质缺陷. 这一发现推动了NPC1和类似遗传疾病的治疗策略.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 尼曼-皮克C1型疾病 (NPC1) 是一种致命的溶酶体疾病,由NPC1基因突变引起.
- NPC1蛋白质错误折叠和错误贩运会破坏胆固醇稳态,导致神经退行.
- 开发有效的NPC1治疗方法需要强大的模型系统来测试药物疗效.
研究的目的:
- 识别恢复折叠,溶酶体贩运和突变NPC1蛋白质功能的小分子.
- 建立和验证一种临床前模型,用于测试NPC1疾病的蛋白静止疗法.
主要方法:
- 使用表达NPC1误解突变的同源人类诱导神经元选化合物.
- 用mo56-基胆固醇 (mo56Hc) 进行药理护送治疗.
- 产生和表征表达人类常见NPC1突变 (I1061T) 的小鼠.
主要成果:
- Mo56Hc被确定为多个NPC1突变的强有力的药理伴侣.
- 人化的NPC1突变小鼠重复了疾病表型,包括蛋白质贩运缺陷和脂质储存.
- 鼠标模型对mo56Hc表现出治疗反应,反映了细胞结果.
结论:
- 通过纠正蛋白质缺陷,Mo56Hc显示出作为NPC1疾病治疗剂的前景.
- 开发的人性化NPC1小鼠模型为临床前药物测试提供了一个有价值的平台.
- 这项研究为验证NPC1和其他遗传疾病的蛋白静止疗法建立了一个范例.
相关概念视频
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:16In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K